News | Mammography | September 25, 2015

Nearly Half of U.S. States Sporting Breast Density Inform Laws

New map tool allows tracking of legislative progress across the country

breast density inform laws, DenseBreast-info.org, map, legislation

Image courtesy of DenseBreast-info.org

September 25, 2015 — With October and Breast Cancer Awareness Month approaching, educational site www.DenseBreast-info.org reported that 24 U.S. states have adopted legislation requiring healthcare providers to notify women whose mammograms reveal dense fibroglandular breast tissue. To track the progress of legislation across the country, the site has created a color-coded map separating states into five categories:

  • States with a law requiring notification on the books (24);
  • States that suggest notification (2);
  • States with a 2015 or 2016 bill (8);
  • States with no active bill (16); and
  • States that offer some level of insurance coverage related to breast density screening (4).

Federal legislative efforts are still ongoing, with separate bills introduced in the U.S. House (HR 716) and Senate (S 370); HR 716 had 30 cosponsors as of Sept. 20 and S 370 had 20 cosponsors at that time.

For more information: www.densebreast-info.org

Related Content

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing

stock.adobe.com / netsign

Feature | Radiology Business | July 02, 2019 | By William W. Pinsky, M.D., FAAP, FACC, and Mandeep R. Mehra, M.D., MBBS, MSc, FRCP
As we strive to process today’s successive news cycles involving negative reports about immigration, it is easy for m
News | Radiology Business | June 27, 2019
Blue Earth Diagnostics, a molecular imaging diagnostics company, announced that a definitive agreement has been signe